INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Genius Group Limited of Class Action Lawsuit and Upcoming Deadlines

Pomerantz filed a class action accusing Citadel Securities and Virtu of spoofing—submitting and canceling buy/sell orders to mislead price and order-flow dynamics—in Genius securities. The complaint alleges Genius shares fell 22% without material company news, alongside spoofing spikes; e.g., during the week of Feb. 10, 2025 Citadel reportedly traded 23M+ shares off-exchange (nearly half of off-exchange volume) and Virtu nearly 11M (20%+), with short volume rising from 53% to 61%. If substantiated, the allegations point to market-structure manipulation and potential securities-law liability, though this is not a completed adjudication yet.

Analysis

This is primarily a market-structure overhang, not a fundamental event, so the first-order impact on GNS is mostly through liquidity quality, borrow, and sentiment rather than any direct earnings mechanism. The filing can widen spreads and make price discovery less reliable, but because it is only an allegation, the effect usually decays quickly unless it is followed by a regulator or exchange action within the next 2-6 weeks.

The bigger second-order implication is for public market makers and internalizers. If this narrative gains traction, scrutiny on off-exchange routing and order-handling could incrementally favor lit venues and hurt names with high internalization exposure, especially Virtu (VIRT) as a public proxy; Citadel remains private, but the broader market-making complex could see a higher compliance discount. For GNS, the risk cuts both ways: the complaint can attract event-driven shorts, but it can also reinforce a retail squeeze setup if traders frame the stock as structurally manipulated.

Over 1-3 months, the key catalyst is whether the case draws parallel SEC/FINRA attention or survives early dismissal motions. Without that, this is mostly noise and likely overtraded. The contrarian view is that the market may be overestimating durability: most such filings create volatility and legal headlines, but only a small subset materially changes liquidity provision or economics for the issuer.

Key Decisions for Investors

• No standalone directional trade in GNS on the filing alone; treat as a volatility event and wait for either a regulator follow-on or a meaningful borrow/volume shift before taking risk.
• If GNS rallies sharply on retail momentum, consider a tactical put spread or small short against strength for 2-4 weeks; thesis fails if no SEC/FINRA action appears and borrow remains unstable.
• Use VIRT as the cleanest public proxy for any escalation in market-making scrutiny; a relative short VIRT vs long NDAQ/CBOE becomes attractive only if additional complaints, subpoenas, or exchange enforcement surface within 1-3 months.
• Set an alert on GNS borrow cost and off-exchange volume; if both spike, the more interesting trade may be long-volatility rather than directional equity exposure.